Chronotherapy of malaria: identification of drug-sensitive stage of parasite and timing of drug delivery for improved therapy.
The cyclic nature of malarial fever in conjunction with the pharmacokinetic characteristics of antimalarial drugs, call for the conception of a chrono-therapeutic approach for the treatment of the disease. An experimental murine malarial model was devised using the highly synchronous species Plasmodium vinckei petteri to test this rationale. Sub-curative doses of chloroquine were injected sub-cutaneously to mice either during the prepatent period or during patent infection. Inspection of the effect of drug applied at different stages of the parasitic cycle, revealed that medium size trophozoites (MT) were the most susceptible stage to chloroquine, while ring and young trophozoite stages were refractory to the drug. Chloroquine given during these latter stages, affected the parasites when they developed into the MT stage. Drug treatment during the MT stage phase-shifted the schizogonic cycle by 18 hours. Hence, treatment with two consecutive injections given 18 hours apart, i.e. timed to the overwhelming presence of the MT stage in the circulation, gave the best therapeutic results.
Cambie
G
G
Laboratoire de Protozoologie et Parasitologie comparée, EPHE, Muséum National d'Histoire Naturelle, Paris.
Caillard
V
V
Beauté-Lafitte
A
A
Ginsburg
H
H
Chabaud
A
A
Landau
I
I
D000818:Animals; D002738:Chloroquine / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D007279:Injections, Subcutaneous; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D010507:Periodicity; D010961:Plasmodium / Q000187:drug effects*; D013997:Time Factors
D002738:Chloroquine